Methyl aziridine-2-carboxylate, 97%, 100mg

ethyl 1H-1,2,3-benzotriazole-6-carboxylate, 95%, 5g

tert-Butyl 4-(4-bromo-2-fluorobenzoyl)piperidine-1-carboxylate, 97%, 100mg

6-[[7-(N,N-Dimethylaminosulfonyl)-2,1,3-benzoxadiazol-4-yl]amino]hexanoic Acid>98.0%(HPLC)(T)100mg

4-(N-Tert-Butoxycarbonyl)aminophenylboronic acid, 98.0%, 1g

4H-FURO[3,2-C]PYRAN-2(6H)-ONE, 4-HYDROXY-, 99%, 25mg

GC capillary column ROTI®Cap-5, 25 m, 0.53 mm, 2.00 µm, 1 Piece(s)

4-(2-Bromoethoxy)benzaldehyde, 95.0%, 5g

N,N-Dicyclohexylcarbodiimide (DCC), 500 g, >=98%, glass packaging

3-(1-Methoxyethyl)aniline, 95%, 10g

4-Methyl-1-(oxan-4-ylmethyl)-1H-pyrazol-5-amine, >95%, 1g

BOC-LYS(Z)-OSU, 95.0%, 25g

1-Bromo-3-[(2-methylpropoxy)methyl]benzene, 95%, 2.5g